Navigation Links
Erchonia & InnerScope Hearing Technologies to Conduct FDA Clinical Trial to Treat Tinnitus with Low Level Laser Technology
Date:11/7/2018

Erchonia Corporation, the global leader in the manufacturing and development of low level laser therapy technology (“3LT”), today announces a joint development agreement with InnerScope Hearing Technologies. Under the agreement, Erchonia and InnerScope will conduct clinical research and trials for the purpose of obtaining 510(k) clearances from the FDA for 3LT devices to treat hearing-related conditions, including tinnitus.

Erchonia and InnerScope expect to be the first to receive 510(k) clearance from the FDA for a treatment protocol for relief of tinnitus symptoms — not tinnitus “maskers” or management devices which are the only currently available options for patients. The companies have already received approval under FDA regulations from the Institutional Review Board for their initial clinical trial.

Commonly referred to as “ringing in the ears,” tinnitus is the perception of sound when no actual external noise is present. Approximately 20 percent of the world's population suffers from tinnitus, experiencing buzzing, hissing, whistling, swooshing, or clicking. Those with intolerable tinnitus also often suffer from higher rates of anxiety, depression, low self-esteem, and poor quality of life.

“We’re looking forward to exploring low level laser’s impact on hearing disorders, especially on tinnitus, which can be debilitating,” says Steve Shanks, president of Erchonia Corporation. “We’re hopeful our partnership with InnerScope can make a real difference in patients’ lives and eventually provide a scientifically-proven, non-invasive option.”

For more information on the partnership, please visit http://www.erchonia.com.

About Erchonia Corporation
Based in Melbourne, Florida, family-owned Erchonia is the global leader in the manufacturing and development of low level laser therapy technology (“3LT”). From humble beginnings in a garage in 1996, Erchonia today develops and sells the most advanced, non-invasive 3LT medical equipment on the market in over 50 countries. With more than 15 clearances from the FDA, Erchonia remains passionately committed to effective, research-based 3LT solutions for a wide variety of conditions — from managing chronic pain to promoting fat loss. For more information, please visit http://www.erchonia.com.

About InnerScope Hearing Technologies
InnerScope Hearing Technologies (INND) is a rapidly expanding consolidator of the hearing aid industry. Management is applying decades of profitable industry experience and technology to an antiquated and disjointed industry, unlocking scale and efficiency, which will serve all of InnerScope’s stakeholders. Its direct-to-consumer model is revolutionizing the industry with its Walmart.com relationship representing a paramount shift in the consumption of hearing aids by the hearing impaired. In addition InnerScope plans to continue to open, acquire, and operate a physical chain of audiological and retail hearing device clinics. InnerScope’s mission is to serve approximately 1.2 billion people around the globe that are suffering with 25 db or greater hearing loss across the entire hearing impaired vertical from R&D and manufacturing through direct consumer sales and services. For more information, please visit http://www.innd.com.

Read the full story at https://www.prweb.com/releases/erchonia_innerscope_hearing_technologies_to_conduct_fda_clinical_trial_to_treat_tinnitus_with_low_level_laser_technology/prweb15895543.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Research and Markets - Global Liposuction Market 2016-2020 - Key Vendors are Cynosure, Erchonia & Genesis Biosystems
2. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
3. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
4. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
5. Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference
6. Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets
7. The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
8. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
9. Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalDatas 700 Market Analysts
10. Heska Corporation to Present at the Stifel Dental & Veterinary Conference
11. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/14/2019)... ... ... Provezza Laboratories is pleased to announce the launch of its ... black elderberry extracts. This new premium elderberry syrup delivers 30mg of polyphenols per dose, ... “Our dedicated team has traveled around the world and worked extremely hard to research ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... approval for their viscoelastic disc replacement. The CE Mark approval was received as ... of biocompatibility and biomechanical cervical disc testing and supporting clinical data regarding the ...
(Date:3/13/2019)... ... March 13, 2019 , ... Guard RFID Solutions Inc., a ... Tag (PT-3), a small and lightweight wearable RFID tag with a user-activated push ... in hazardous industrial environments. , “We have developed our most versatile tag to ...
Breaking Medicine Technology:
(Date:3/14/2019)... ... March 14, 2019 , ... When:    Wednesday, March 20 - ... 1900 Long Beach Blvd., Long Beach, CA 90806 , What:    Los Angeles County Supervisor ... city officials, and other partners to celebrate the start of construction of The ...
(Date:3/14/2019)... ... March 14, 2019 , ... Luneau Technology is ... professional market at the 2019 Vision Expo East in New York City. , ... ways to practice more efficiently while maintaining the highest standards of care. The ...
(Date:3/14/2019)... ... March 14, 2019 , ... The ... emotional learning (SEL) program— Sanford Harmony —today announced a new partnership with the ... empowers kids to develop lifelong healthy habits. The partnership will focus on building ...
(Date:3/14/2019)... ... March 13, 2019 , ... ... a recent validation study conducted by Intermountain Healthcare of its proprietary in vitro ... 14, 2019 . NVDx is a pre-revenue oncology company that is focused ...
(Date:3/14/2019)... ... ... Shamangelic Healing founder Anahata Ananda was recently a guest on the ... into what it means to have your “inner Shaman” awakened opens with a blessing, ... to draw in listeners to the moment. With full attention and anticipation setting the ...
Breaking Medicine News(10 mins):